HBK Sorce Advisory’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.24M | Buy |
39,824
+1,078
| +3% | +$62.8K | 0.04% | 143 |
|
|
2025
Q4 | $2.4M | Buy |
38,746
+451
| +1% | +$21.7K | 0.06% | 141 |
|
|
2025
Q3 | $1.67M | Buy |
38,295
+2,472
| +7% | +$115K | 0.04% | 159 |
|
|
2025
Q2 | $1.66M | Sell |
35,823
-873
| -2% | -$42.9K | 0.04% | 157 |
|
|
2025
Q1 | $2.24M | Buy |
36,696
+2,232
| +6% | +$130K | 0.07% | 122 |
|
|
2024
Q4 | $1.95M | Sell |
34,464
-459
| -1% | -$25.6K | 0.06% | 137 |
|
|
2024
Q3 | $1.81M | Buy |
34,923
+3,379
| +11% | +$159K | 0.06% | 144 |
|
|
2024
Q2 | $1.31M | Sell |
31,544
-1,034
| -3% | -$46.3K | 0.05% | 176 |
|
|
2024
Q1 | $1.77M | Buy |
32,578
+1,159
| +4% | +$59K | 0.06% | 154 |
|
|
2023
Q4 | $1.61M | Sell |
31,419
-3,675
| -10% | -$193K | 0.06% | 159 |
|
|
2023
Q3 | $2.04M | Buy |
35,094
+19
| +0.1% | +$1.16K | 0.09% | 131 |
|
|
2023
Q2 | $2.24M | Sell |
35,075
-3,482
| -9% | -$233K | 0.09% | 128 |
|
|
2023
Q1 | $2.67M | Sell |
38,557
-35,417
| -48% | -$2.5M | 0.12% | 111 |
|
|
2022
Q4 | $5.32M | Buy |
73,974
+40,243
| +119% | +$3.03M | 0.14% | 102 |
|
|
2022
Q3 | $2.4M | Buy |
33,731
+5,459
| +19% | +$396K | 0.16% | 100 |
|
|
2022
Q2 | $2.18M | Sell |
28,272
-6,338
| -18% | -$483K | 0.16% | 97 |
|
|
2022
Q1 | $2.53M | Sell |
34,610
-330
| -0.9% | -$22.2K | 0.14% | 108 |
|
|
2021
Q4 | $2.18M | Sell |
34,940
-31
| -0.1% | -$1.82K | 0.11% | 132 |
|
|
2021
Q3 | $2.07M | Sell |
34,971
-1,895
| -5% | -$125K | 0.11% | 128 |
|
|
2021
Q2 | $2.46M | Sell |
36,866
-466
| -1% | -$30.4K | 0.14% | 114 |
|
|
2021
Q1 | $2.36M | Buy |
37,332
+529
| +1% | +$32.9K | 0.14% | 110 |
|
|
2020
Q4 | $2.28M | Sell |
36,803
-65
| -0.2% | -$4K | 0.14% | 107 |
|
|
2020
Q3 | $2.22M | Buy |
36,868
+1,136
| +3% | +$68.4K | 0.16% | 93 |
|
|
2020
Q2 | $2.1M | Buy |
35,732
+7,890
| +28% | +$472K | 0.16% | 96 |
|
|
2020
Q1 | $1.55M | Sell |
27,842
-1,103
| -4% | -$67.4K | 0.15% | 101 |
|
|
2019
Q4 | $1.86M | Buy |
28,945
+3,282
| +13% | +$188K | 0.16% | 107 |
|
|
2019
Q3 | $1.3M | Sell |
25,663
-1,297
| -5% | -$61K | 0.12% | 124 |
|
|
2019
Q2 | $1.22M | Sell |
26,960
-4,273
| -14% | -$199K | 0.12% | 133 |
|
|
2019
Q1 | $1.49M | Buy |
31,233
+9,993
| +47% | +$498K | 0.15% | 115 |
|
|
2018
Q4 | $1.1M | Sell |
21,240
-255
| -1% | -$13.7K | 0.13% | 135 |
|
|
2018
Q3 | $1.33M | Sell |
21,495
-713
| -3% | -$42.3K | 0.15% | 104 |
|
|
2018
Q2 | $1.23M | Sell |
22,208
-691
| -3% | -$37.3K | 0.14% | 110 |
|
|
2018
Q1 | $1.45M | Buy |
22,899
+552
| +2% | +$35.5K | 0.18% | 93 |
|
|
2017
Q4 | $1.37M | Buy |
22,347
+5,028
| +29% | +$314K | 0.16% | 100 |
|
|
2017
Q3 | $1.1M | Buy |
17,319
+981
| +6% | +$57.3K | 0.17% | 89 |
|
|
2017
Q2 | $910K | Buy |
+16,338
| New | +$889K | 0.15% | 103 |
|
|
2017
Q1 | – | Sell |
-16,207
| Closed | -$889K | – | 318 |
|
|
2016
Q4 | $947K | Buy |
16,207
+171
| +1% | +$9.35K | 0.17% | 96 |
|
|
2016
Q3 | $865K | Buy |
16,036
+3,143
| +24% | +$202K | 0.17% | 89 |
|
|
2016
Q2 | $948K | Buy |
12,893
+2,590
| +25% | +$183K | 0.2% | 83 |
|
|
2016
Q1 | $658K | Buy |
10,303
+2,931
| +40% | +$185K | 0.16% | 95 |
|
|
2015
Q4 | $507K | Buy |
7,372
+74
| +1% | +$4.89K | 0.13% | 111 |
|
|
2015
Q3 | $432K | Buy |
7,298
+202
| +3% | +$12.8K | 0.14% | 104 |
|
|
2015
Q2 | $472K | Sell |
7,096
-31
| -0.4% | -$2.04K | 0.16% | 102 |
|
|
2015
Q1 | $460K | Sell |
7,127
-531
| -7% | -$33.2K | 0.16% | 100 |
|
|
2014
Q4 | $452K | Sell |
7,658
-1,448
| -16% | -$81.7K | 0.16% | 105 |
|
|
2014
Q3 | $466K | Buy |
9,106
+747
| +9% | +$37.3K | 0.17% | 87 |
|
|
2014
Q2 | $406K | Sell |
8,359
-1,749
| -17% | -$86.2K | 0.14% | 99 |
|
|
2014
Q1 | $525K | Buy |
10,108
+3,344
| +49% | +$178K | 0.19% | 81 |
|
|
2013
Q4 | $359K | Buy |
6,764
+4
| +0.1% | +$204 | 0.13% | 105 |
|
|
2013
Q3 | $313K | Sell |
6,760
-6,780
| -50% | -$298K | 0.13% | 115 |
|
|
2013
Q2 | $606K | Buy |
+13,540
| New | +$588K | 0.13% | 112 |
|
Other funds holding BMY
VCM
VPM
HBK Sorce Advisory's BMY Position: Q1 2026 in Review
HBK Sorce Advisory increased its Bristol-Myers Squibb (BMY) stake by 2.8% in Q1 2026, buying an estimated $62.8K and bringing the position to 39,824 shares worth $2.24M. The position accounts for 0.04% of the portfolio, ranked #143.
HBK Sorce Advisory first reported a position in BMY in Q2 2013 and has held it in 51 quarters since. The position peaked at $5.32M in Q4 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- HBK Sorce Advisory held 39,824 shares of Bristol-Myers Squibb worth $2.24M as of Q1 2026.
- HBK Sorce Advisory bought 1,078 Bristol-Myers Squibb shares in Q1 2026, an estimated $62.8K.
- Bristol-Myers Squibb made up 0.04% of HBK Sorce Advisory's portfolio in Q1 2026, its #143 holding.
- HBK Sorce Advisory first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 51 quarters since.
- HBK Sorce Advisory's Bristol-Myers Squibb position peaked at $5.32M in Q4 2022.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.